The role of E3 ubiquitin ligases in cancer pathogenesis and treatment with Ionising Radiation (IR)
The role of E3 ubiquitin ligases in cancer pathogenesis and treatment with Ionising Radiation (IR)
批准号:
MR/X006980/1
负责人:
Vincenzo D'Angiolella
金额:
$312.37万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Each cell in our body contains thousands of molecular machines which are called proteins. Proteins execute dedicated functions in the cells. The information on the coding of such proteins is retained in the form of a long quaternary code in the nuclei of each cell as deoxyribonucleic acid (DNA). Each cell will have proteins dedicated to repair the damage caused by environmental stress to DNA, proteins dedicated to allowing cells to multiply their DNA copy and many other functions. The abundance of each protein in the cell must be carefully regulated to sustain cell survival and the integrity of the information contained in the DNA. Cancer cells have, typically altered protein abundance contributing to their increased proliferation states. The D'Angiolella laboratory studies the mechanisms underlying protein homeostasis in the cells and focuses on how these mechanisms are altered in cancer and contribute to cancer development. The understanding of these processes will help develop treatments to specifically kill the cancer cells leaving the normal tissue intact. The laboratory used genetic screens to identify the mechanisms of protein homeostasis at the basis of the repair of damaged DNA after treatment with radiation therapy. In the current proposal, the laboratory proposes to investigate in detail the mechanisms highlighted by genetic screens. Specifically, the study will focus on two proteins which control how the DNA is cleaved in the cells after radiation treatment to execute error prone or error-free mechanisms of DNA repair. The balance between these mechanisms is crucial to allow cells to survive in the presence of many DNA damaging lesions induced by radiotherapy. Altering these mechanisms in cancer cells could favour cell death and inflammation, eliciting an anti-cancer response. Thus, our studies will clarify the contribution of protein homeostasis in preservation of the genome integrity of any cell and, at the same time, reveal potential targets to exploit for cancer therapy.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1042/bcj20220019
发表时间:
2022-03-18
期刊:
The Biochemical journal
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1038/s41418-022-00983-4
发表时间:
2022-10
期刊:
CELL DEATH AND DIFFERENTIATION
影响因子:
12.4
作者:
[Chen, Zhuoyao, Ioris, Rafael M., Richardson, Stacey, Van Ess, Ava N., Vendrell, Iolanda, Kessler, Benedikt M., Buffa, Francesca M., Busino, Luca, Clifford, Steven C., Bullock, Alex N., D'Angiolella, Vincenzo]
通讯作者:
D'Angiolella, Vincenzo
DOI:
10.1016/j.molcel.2023.11.037
发表时间:
2023-12
期刊:
Molecular cell
影响因子:
16
作者:
[Varun Gopala Krishna;Verena Gudrun Gautsch;V. D’Angiolella]
通讯作者:
Varun Gopala Krishna;Verena Gudrun Gautsch;V. D’Angiolella
Role and regulation of cyclin F in the cellular responses to ionizing radiation (IR).
-
批准号:MC_UU_00001/7
-
项目类别:Intramural
-
资助金额:$225.92万
-
财政年份:2017
-
负责人:Vincenzo D'Angiolella
-
依托单位:
国内基金
海外基金
登录
查看更多内容
E3泛素连接酶HERC2介导NCOA4-FTH-Fe轴调控神经元铁自噬在机械性脊髓损伤中的作用及机制研究
-
批准号:2026JJ81936
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘富兵
-
依托单位:
E3 泛素连接酶 RNF123 调控柠檬酸转运蛋白SLC25A1 线粒体定位介导代谢功能障碍相关脂肪性肝炎的作用和机制研究
-
批准号:ZCLMS26H0702
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗武
-
依托单位:
E3泛素连接酶RNF167在KSHV相关肿瘤发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李婷婷
-
依托单位:
E3泛素连接酶FBXO17泛素化调控结肠癌细胞侵袭转移的机制研究
-
批准号:2026JJ80375
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘佳
-
依托单位:
基于E3泛素连接酶SMURF1/2靶向Runx2降解研究补肾活血方促进骨髓间充质干细胞成骨分化防治骨质疏松的作用机制
-
批准号:JCZRLH202601520
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
E3泛素连接酶OsELx调控水稻耐冷性的分子机制解析
-
批准号:2026JJ60399
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:严涛
-
依托单位:
E3泛素连接酶KLHL13通过泛素化降解HIF-1α抑制TGF-β通路在瘢痕疙瘩形成中的作用与机制研究
-
批准号:2026JJ81897
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈艳明
-
依托单位:
E3泛素连接酶通过K63型泛素化修饰调控三阴性乳腺癌侵袭转移的机制研究
-
批准号:JCZRLH202601624
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
抑制E3泛素连接酶RNF182通过稳定MFN2激活线粒体自噬抑制瘢痕疙瘩形成
-
批准号:2026JJ81106
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张建飞
-
依托单位:
铁过载介导SCF-FBXL4泛素E3连接酶复合物-BNIP3/NIX线粒体自噬通路促进眼表炎症参与干眼发病机制
-
批准号:2026JJ81109
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏世刚
-
依托单位: